Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1]
4
(1 Review)
|
(22 Publications)
Mouse Monoclonal FOXA1 antibody. Carrier free. Suitable for Flow Cyt, WB, ICC/IF, IHC-P and reacts with Human, Recombinant fragment - Human samples. Cited in 22 publications. Immunogen corresponding to Recombinant Fragment Protein within Human FOXA1 aa 350 to C-terminus.
View Alternative Names
HNF3A, TCF3A, FOXA1, Hepatocyte nuclear factor 3-alpha, HNF-3-alpha, HNF-3A, Forkhead box protein A1, Transcription factor 3A, TCF-3A
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)
ab55178 at 10 ug/ml staining FOXA1 in human HepG2 cells by Immunocytochemistry/ Immunofluorescence.
This image was generated using the ascites version of the product.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)
FOXA1 antibody (ab55178) used in immunohistochemistry at 3ug/ml on formalin fixed and paraffin embedded human salivary gland.
This image was generated using the ascites version of the product.
- Flow Cyt
Unknown
Flow Cytometry - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)
Overlay histogram showing HepG2 cells stained with ab55178 (red line). The cells were fixed with 4 % paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab55178, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 1μg/1x106 cells ) used under the same conditions. Acquisition of >5,000 events was performed.
This image was generated using the ascites version of the product.
- WB
Lab
Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)
Lanes 1- 2 : Merged signal (red and green). Green - ab55178 observed at 49 kDa. Red - Anti-GAPDH antibody[EPR16891] - Loading Control (ab181602) observed at 37 kDa.
ab55178 was shown to react with FOXA1 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab261823 (knockout cell lysate ab256920) was used. Wild-type HeLa and FOXA1 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab55178 and Anti-GAPDH antibody[EPR16891] - Loading Control (ab181602) overnight at 4°C at a 1 in 500 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Mouse IgG H&L (IRDye®800CW) preadsorbed (ab216772) and Goat Anti-Rabbit IgG H&L (IRDye®680RD) preadsorbed (ab216777) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
HeLa cells are predicted to express FOXA1, with no expression of FOXA2 or FOXA3.
All lanes:
Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (ab55178) at 1/500 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
FOXA1 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human FOXA1 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-foxa1-knockout-hela-cell-line-ab261823'>ab261823</a>)
Predicted band size: 49 kDa
Observed band size: 49 kDa
false
- WB
Unknown
Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)
FOXA1 antibody (ab55178) at 1ug/lane + HepG2 cell lysate at 25ug/lane.
This image was generated using the ascites version of the product.
All lanes:
Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (ab55178)
Predicted band size: 49 kDa
false
- WB
Lab
Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (AB55178)
Western blot : Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] ab55178 staining at 1/500 dilution, shown in green; Rabbit anti GST (ab111947) loading control staining at 1/200 dilution, shown in magenta. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse 800CW & Goat anti-Rabbit 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-FOXA1 + FOXA2 + FOXA3 antibody [1B1] (ab55178) at 1/500 dilution
Lane 1:
FOXA1 Recombinant Protein at 0.1 µg
Lane 2:
FOXA2 Recombinant Protein at 0.1 µg
Lane 3:
FOXA3 Recombinant Protein at 0.1 µg
Secondary
All lanes:
Goat anti-Mouse 800CW & Goat anti-Rabbit 680RD at 1/20000 dilution
Predicted band size: 52 kDa,50 kDa,37 kDa
Observed band size: 78 kDa,76 kDa,63 kDa
false
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FOXA1 influences the transcriptional control of genes essential for organ development and metabolic regulation. It acts as a pioneer factor opening chromatin structure to enable access for other transcription factors. FOXA1 integrates into complexes that involve histone modification affecting the chromatin state and transcription of target genes. This function is necessary for the proper differentiation and function of several tissues.
Pathways
FOXA1 participates significantly in the androgen receptor signaling pathway and the estrogen receptor signaling pathway. It interacts closely with androgen receptor facilitating the expression of genes that influence cell growth and proliferation. The involvement of FOXA1 in these pathways highlights its critical role in pathways that regulate hormone-responsive cancers and metabolic processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (22)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular sciences 26: PubMed40724920
2025
Applications
Unspecified application
Species
Unspecified reactive species
NPJ precision oncology 9:127 PubMed40319192
2025
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 26:443-469 PubMed39633177
2024
Applications
Unspecified application
Species
Unspecified reactive species
Annals of surgery open : perspectives of surgical history, education, and clinical approaches 5:e385 PubMed38883957
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 39:101807 PubMed38235618
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 84:476-489.e10 PubMed38211589
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 13:1120329 PubMed36816919
2023
Applications
Unspecified application
Species
Unspecified reactive species
Computational and mathematical methods in medicine 2022:3110330 PubMed36003920
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:6636 PubMed34789735
2021
Applications
Unspecified application
Species
Unspecified reactive species
Environmental toxicology 36:2093-2104 PubMed34254728
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com